Promedior News
Most Popular Promedior Story
Promedior
Little Promedior aims big in new approach to fibrosis For a little start-up, Promedior is aiming at a very big therapeutic target. The two-year-old, Malvern, PA-based biotech company only just Read more...
Latest Headlines
- March 16, 2010
- February 8, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
